Department of Thoracic Surgery, Nanjing Chest Hospital, Treatment and Research Center for Pulmonary Nodule in Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, 210029, China.
BMC Surg. 2020 Nov 30;20(1):301. doi: 10.1186/s12893-020-00910-9.
To investigate whether tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage has better short-term outcomes than non-intubated approach with chest tube drainage.
Data were collected retrospectively from January 2017 and December 2019. Tubeless group included 55 patients with pulmonary nodules underwent tubeless uniportal thoracoscopic wedge resection, 211 patients underwent non-intubated uniportal thoracoscopic wedge resection with chest tube drainage were included in drainage group. Peri-operative outcomes between two groups were compared.
After 1:1 matching, 110 patients remained for analysis, baseline demographic and clinical variables were comparable between the two groups. Mean incision size was 3 cm in both group. Mean operative time was 59.3 min in tubeless group and 52.8 min in drainage group. The detectable mean lowest SpO and mean peak EtCO during operation was acceptable in both groups. Conversion to intubated ventilation or thoracotomy was not required. No patient failed the air leak test and did not undergo a tubeless procedure. Mean postoperative hospital stay was 1.5 days in tubeless group and 2.5 days in drainage group. Residual pneumothorax or subcutaneous emphysema was not frequent and mild in tubeless group. Side effects were rare and mild, including cough and hemoptysis. No re-intervention or readmission occurred. The postoperative VAS score was significantly lower in tubeless group.
Tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage is feasible and safe for selected patients with peripheral pulmonary nodules, it might reduce post-operation pain and lead to faster recovery.
为了研究改良漏气试验和胸腔引流的无管单孔胸腔镜楔形切除术是否比带管非插管方法具有更好的短期结果。
数据来自 2017 年 1 月至 2019 年 12 月的回顾性收集。无管组包括 55 例肺结节患者行无管单孔胸腔镜楔形切除术,引流组包括 211 例肺结节患者行带管非插管单孔胸腔镜楔形切除术。比较两组患者围手术期结局。
经过 1:1 匹配,110 例患者仍用于分析,两组患者的基线人口统计学和临床变量相似。两组的平均切口大小均为 3cm。无管组的平均手术时间为 59.3 分钟,引流组为 52.8 分钟。两组术中可检测到的最低 SpO 和平均 EtCO 峰值均在可接受范围内。不需要转为插管通气或开胸。无患者漏气试验失败且未进行无管操作。无管组的平均术后住院时间为 1.5 天,引流组为 2.5 天。无管组的残余气胸或皮下气肿不常见且较轻。副作用罕见且较轻,包括咳嗽和咯血。无再次干预或再次入院。无管组术后 VAS 评分显著降低。
改良漏气试验和胸腔引流的无管单孔胸腔镜楔形切除术对选择的周围性肺结节患者是可行且安全的,可能减少术后疼痛并促进更快恢复。